High-risk lesions of the breast: concurrent diagnostic tools and management recommendations

F Catanzariti, D Avendano, G Cicero… - Insights into …, 2021 - Springer
Breast lesions with uncertain malignant behavior, also known as high-risk or B3 lesions, are
composed of a variety of pathologies with differing risks of associated malignancy. While …

Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia: systematic review and meta-analysis of 6458 lesions

S Schiaffino, M Calabrese, EF Melani, RM Trimboli… - Radiology, 2020 - pubs.rsna.org
Background Management of percutaneously diagnosed pure atypical ductal hyperplasia
(ADH) is an unresolved clinical issue. Purpose To calculate the pooled upgrade rate of …

Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia

A Pena, SS Shah, RT Fazzio, TL Hoskin… - Breast cancer research …, 2017 - Springer
Purpose Atypical ductal hyperplasia (ADH) identified on percutaneous breast biopsy
represents a high-risk lesion, upgrading to cancer with surgical excision in~ 7–45.8% of …

[HTML][HTML] Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review

KL Mooney, LW Bassett, SK Apple - Modern Pathology, 2016 - Elsevier
Optimal management of high-risk breast lesions detected by mammogram yielding atypical
ductal hyperplasia, flat epithelial atypia, atypical lobular hyperplasia, lobular carcinoma in …

[HTML][HTML] Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision

J Kim, W Han, JW Lee, JM You, HC Shin, SK Ahn… - The Breast, 2012 - Elsevier
OBJECTIVES: The present study tried to identify factors predictive of upstaging from
ultrasound-guided core needle biopsy (CNB)-diagnosed ductal carcinoma in situ (DCIS) to …

Atypical ductal hyperplasia diagnosed at sonographically guided core needle biopsy: frequency, final surgical outcome, and factors associated with underestimation

B Mesurolle, JCH Perez, F Azzumea… - American Journal of …, 2014 - Am Roentgen Ray Soc
OBJECTIVE. The purposes of this article were to review the mammographic and
sonographic features of breast masses yielding atypical ductal hyperplasia (ADH) at …

Management of high-risk breast lesions

M Bahl - Radiologic Clinics, 2021 - radiologic.theclinics.com
More than 10% of breast biopsies performed based on findings at mammography yield
highrisk lesions (HRLs). 1 HRLs refer to a group of heterogeneous lesions that can be …

[HTML][HTML] Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy

I Deshaies, L Provencher, S Jacob, G Côté, J Robert… - The Breast, 2011 - Elsevier
Previous studies have shown that 4–54% of breast lesions reported on core biopsies as
atypical ductal hyperplasia (ADH) are upgraded on further excision to ductal carcinoma in …

Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy

BJ Chae, A Lee, BJ Song, SS Jung - World Journal of Surgical Oncology, 2009 - Springer
Background Percutaneous core needle biopsy (CNB) is considered to be the standard
technique for histological diagnosis of breast lesions. But, it is less reliable for diagnosing …

Nomogram to predict the likelihood of upgrade of atypical ductal hyperplasia diagnosed on a core needle biopsy in mammographically detected lesions

T Khoury, X Chen, D Wang, P Kumar, M Qin… - …, 2015 - Wiley Online Library
Aims To estimate the likelihood of the upgrade for atypical ductal hyperplasia (ADH)
diagnosed on a core needle biopsy of a mammographically detected lesion. Methods and …